Global Active Pharmaceutical Ingredients (API) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-01-22
- Report ID: 42042
- Pages: 101
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Marketss analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Active Pharmaceutical Ingredients (API) market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Active Pharmaceutical Ingredients (API) Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Active Pharmaceutical Ingredients (API) Market
SGS South Africa
Ketlaphela Pharmaceutical
Yokogawa South Africa
Aurobindo pharma
Cipla
Haerbin Pharmaceutical
Lupin
Bachem
...
Major Type of Active Pharmaceutical Ingredients (API) Covered in Prudent Markets report:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Application Segments Covered in Prudent Markets Market
Synthetic APIs
Biotech APIs
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Active Pharmaceutical Ingredients (API) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 CNS -Product Introduction and Major Manufacturers
1.1.2 Cardiovascular -Product Introduction and Major Manufacturers
1.1.3 Genitourinary/Hormonal Drugs -Product Introduction and Major Manufacturers
1.1.4 Respiratory -Product Introduction and Major Manufacturers
1.1.5 Rheumatology -Product Introduction and Major Manufacturers
1.1.6 Diabetes -Product Introduction and Major Manufacturers
1.1.7 Oncology -Product Introduction and Major Manufacturers
1.1.8 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.1.1 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.1.2 China Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.2.1 EU Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.2.2 EU Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.3.1 USA Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.3.2 USA Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.4.1 Japan Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.4.2 Japan Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.5.1 India Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.5.2 India Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.6.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.7.1 South America Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.7.2 South America Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
2.8.1 Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
2.8.2 Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Active Pharmaceutical Ingredients (API) Market Assessment by Segment
3.1 Global Active Pharmaceutical Ingredients (API) Capacity and Growth Rate
3.2 Global Active Pharmaceutical Ingredients (API) Sales by Type
3.3 Global Active Pharmaceutical Ingredients (API) Sales Revenue by Type
3.4 Global Active Pharmaceutical Ingredients (API) Consumption by Application
4 Global Active Pharmaceutical Ingredients (API) Market Assessment by Regions
4.1 Global Active Pharmaceutical Ingredients (API) Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Active Pharmaceutical Ingredients (API) Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Active Pharmaceutical Ingredients (API) Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Active Pharmaceutical Ingredients (API) Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Active Pharmaceutical Ingredients (API) Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share of Manufacturers (2019-2020)
6.3 Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share of Manufacturers (2019-2020)
7 Active Pharmaceutical Ingredients (API) Competitive Analysis
7.1 SGS South Africa
7.1.1 SGS South Africa Company Profiles
7.1.2 SGS South Africa Product Introduction
7.1.3 SGS South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Ketlaphela Pharmaceutical
7.2.1 Ketlaphela Pharmaceutical Company Profiles
7.2.2 Ketlaphela Pharmaceutical Product Introduction
7.2.3 Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Yokogawa South Africa
7.3.1 Yokogawa South Africa Company Profiles
7.3.2 Yokogawa South Africa Product Introduction
7.3.3 Yokogawa South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Aurobindo pharma
7.4.1 Aurobindo pharma Company Profiles
7.4.2 Aurobindo pharma Product Introduction
7.4.3 Aurobindo pharma Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Cipla
7.5.1 Cipla Company Profiles
7.5.2 Cipla Product Introduction
7.5.3 Cipla Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Haerbin Pharmaceutical
7.6.1 Haerbin Pharmaceutical Company Profiles
7.6.2 Haerbin Pharmaceutical Product Introduction
7.6.3 Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Lupin
7.7.1 Lupin Company Profiles
7.7.2 Lupin Product Introduction
7.7.3 Lupin Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Bachem
7.8.1 Bachem Company Profiles
7.8.2 Bachem Product Introduction
7.8.3 Bachem Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
